Amanote Research

Amanote Research

    RegisterSign In

ABO Blood Group and Risk of Renal Cell Cancer.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.30.5_suppl.371
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchMedicineOncology
Date

February 10, 2012

Authors
Eunyoung ChoHee-Kyung JohToni K. Choueiri
Publisher

American Society of Clinical Oncology (ASCO)


Related search

ABO Blood Group and Risk of Renal Cell Cancer

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2012English

ABO Blood Group (ABO)

Science-Business eXchange
2010English

Pancreatic Cancer Risk and ABO Blood Group Alleles: Results From the Pancreatic Cancer Cohort Consortium

Cancer Research
Cancer ResearchOncology
2010English

ABO Blood Group, Glycosyltransferase Activity and Risk of Venous Thrombosis

2020English

ABO Blood Group Alleles and Prostate Cancer Risk: Results From the Breast and Prostate Cancer Cohort Consortium (BPC3)

Prostate
OncologyUrology
2015English

Variant ABO Blood Group Alleles, Secretor Status, and Risk of Pancreatic Cancer: Results From the Pancreatic Cancer Cohort Consortium

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

Stomach Cancer and ABO Blood Groups

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1957English

Maternal ABO Blood Group and Adverse Pregnancy Outcomes

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Influence of ABO Blood Group on Sports Performance

Annals of Translational Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy